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Coordinated Dual Cleavages Induced
by the Proteasome Regulator PA28 Lead
to Dominant MHC Ligands
TobiasP.Dick,*‖ThomasRuppert,†Marcus Groettrup,‡ subunits each and presumably carry together 6 catalyti-
cally active sites on their inner surface (Seemu¨ller et al.,Peter M. Kloetzel,‡ Lothar Kuehn,§
1995), with a minimal distance of 28 A˚ from each other.Ulrich H. Koszinowski,† Stefan Stevanovic´,*‖
The two outer rings consist of 7 different a subunitsHansjo¨rg Schild,*‖ and Hans-Georg Rammensee*‖
each. Strings of unfolded proteins are thought to be*Department of Tumorvirus-Immunology
inserted into the cylinder and to be cut by the activeGerman Cancer Research Center
centers; the resulting peptide fragments are then re-Im Neuenheimer Feld 242
leased into the cytosol.D-69120 Heidelberg
In vertebrate cells, the proteolytic fragments pro-†Department of Virology
duced by the proteasome are probably fed into the anti-University of Heidelberg
gen processing machinery. Since peptide presentationIm Neuenheimer Feld 324
by major histocompatibility complex (MHC) class Imole-D-69120 Heidelberg
cules at the cell surface is an intrinsic requirement for‡ Institute of Biochemistry
the immune system’s ability to eradicate virus-infectedMedical Faculty
or -transformed cells (Rammensee et al., 1993), it isHumboldt University Berlin
of pertinence to know exactly how the proteasome isHessische Str. 3-4
involved in this process. Functional studies with miceD-10115 Berlin
(Fehling et al., 1994; Van Kaer et al.,1994) or cells (Arnold§Diabetes Research Institute
et al., 1992; Momburg et al., 1992) lacking g-interferonAuf’m Hennekamp 65
(IFNg) inducible proteasome subunits, LMP2 or LMP7—D-40225 Du¨sseldorf
which replace the constitutive b subunits d and MB-Federal Republic of Germany
1—as well as studies with proteasome inhibitors (Rock
et al., 1994), gave a vague indication that proteasomes
are involved in antigen processing. To clarify their role,
Summary purified proteasomes have been used to address their
enzymatic specificity. The use of artificial substrates
The eukaryotic 20S proteasome is known to associate like amino-terminally blocked tri- or tetrapeptides with
with the IFNg-inducible regulator PA28. We analyzed fluorogenic leaving groups has suggested preferential
thekinetics of product generation by 20Sproteasomes cleavage after hydrophobic or charged amino acids
with and without PA28. In the absence of PA28, the (Boes et al., 1994; Kuckelkorn et al., 1995). Analyzing
20S proteasome rapidly generates peptides that have cleavage of such small substrates, however, is of limited
been cleaved only once, while internal fragments ac- value for the understanding of antigen processing in
cumulate only slowly. In the presence of PA28, prod- vivo, which must involve authentic peptides longer than
ucts generated by two flanking cleavages appear im- 9 amino acids, the usual size of MHC class I ligands.
mediately as main products while the generation of Therefore, proteasomes have been fed with denatured
single-cleavage products is strongly reduced. Kinetic proteins and peptides of 15–25 amino acids length con-
data support a PA28-induced, coordinated double- taining MHC class I ligands (Boes et al., 1994; Dick
cleavage mechanism. In particular, degradation of et al., 1994). In most cases, class I ligands were only
peptides derived from mouse cytomegalovirus pp89 identified among the minor cleavage products, except
and JAK1 kinase in the presence of PA28 leads to for the ovalbumin-derived immunodominant epitope
strongly enhanced production of the respective major SIINFEKL, which was found to be a dominant cleavage
histocompatibility complex ligands and potential pre- product when generated from a 22-mer peptide (Nieder-
cursors. These results show that PA28 profoundly al- mann et al., 1995).
ters the cleavage mechanism of the proteasome and When associated with the ATP-dependent 19S cap
appears to optimize the generation of dominant T-cell complex, the 20S proteasome particle forms part of the
epitopes. 26S proteasome capable of recognizing and degrading
ubiquitylated protein substrates (Hochstrasser, 1995;
Jentsch and Schlenker, 1995). Another protein complexIntroduction
known to associate with the same 20S core particle is
PA28 (the 11S regulator) (Dubiel et al., 1992; Ma et al.,Proteasomes are ubiquitous multisubunit proteases that
1992), composed of two homologous subunits (Mott etdegrade proteins in the cytosol. The structure of an
al., 1994; Ahn et al., 1995) forming a hexa- or heptamericarchaebacterial proteasome determined recently has
ring structure (Gray et al., 1994). PA28, like the protea-been used to predict the structure of the eukaryotic 20S
some subunits LMP2 and LMP7, is induced by IFN; thus,proteasome (Lo¨we et al., 1995). It is a barrel-shaped
it is likely that the peptides produced by the proteasomecomplex of four stacked rings, each consisting of 7
under the influence of PA28 are the ones relevant forsubunits. The two inner rings consist of 7 different b
antigen presentation, since IFN production accompa-
nies viral infection as well as the activation of antigen-
presenting cells and cytotoxic T cells (Oldstone, 1994).‖ Present address: Institute forCell Biology, Departmentof Immunol-
ogy, Auf der Morgenstelle 15, D-72076 Tu¨bingen, Germany. However, functionalprinciples by which PA28 influences
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the generation of peptides by the 20S proteasome are comparison of the amount of different peptides but can
be used tocompare relative levels of individual peptides.not yet established.
To investigate in detail the influence of PA28 on pep-
tide cleavage and specificity of the 20S proteasome and Kinetics of Double Cleavages
to elucidate its role in antigen processing, we analyzed A quantitation of products along the time course demon-
the production of two relevant peptides. The peptide strates that the presence of PA28 leads to an immediate
SYFPEITHI is the most abundant ligand presented by and rapid formation of DCPs (exemplified with the domi-
H-2Kd molecules of the mouse mastocytoma cell line nant DCPs in Figures 2B, 2G, and 2L). At early time
P815 (Falk et al., 1991); it is derived from a normal self points the amount of these fragments was 5- to 50-fold
protein, the tyrosine kinase JAK1 (Harpur et al., 1993), higher than in the absence of PA28. At later time points,
and occurs in an estimated 10,000 copies per cell, however, a much slower but steady accumulation of
whereas the copy number of average class I ligands DCPs in the absence of PA28 reduces the observed
ranges in the lower hundreds (Rammensee et al., 1993). difference in DCP formation. In addition, certain DCPs
The second peptide chosen is YPHFMPTNL, a dominant might be further degraded with time, thereby masking
Ld-presented T cell epitope and natural MHC ligand from the PA28-mediated effect for some products in digests
thepp89 protein of mouse cytomegalovirus (MCMV) that with long incubation times, as observed after 24 hr for
has been shown to be a naturally processed MHC ligand the JAK1-derived DCP 8–16 and the JAK1(D)-derived
(del Val et al., 1991). The basic outline of our experiments DCP 6–14 (Figures 2B and 2G).
isas follows: peptides of 19–25amino acids correspond- On the other hand, PA28 strongly suppresses forma-
ing to the respective protein sequence and containing tion of SCPs, whereas in the absence of PA28 they are
the MHC ligand in themiddle were synthesized and used the main products with a strong initial formation rate
as substrates in kinetic studies with purified mouse 20S (shown for the dominant SCPs in Figures 2D, 2I, and 2N).
proteasomes in the presence or absence of human These observations hold true for all products formed in
PA28. The resulting cleavage products were separated the digests (further examples are summarized in Figures
after different time points by reversed phase HPLC and 2C, 2H, 2M, 2E, 2J, and 2O as relative amounts after 5
identified and quantitated by on-line electrospray mass hr incubation). However, the general cleavage pattern
spectrometry. (Figures 2A, 2F, and 2K) is not changed by PA28. The
only difference in the presence of PA28 appears to be
the combined usage of two such cleavage sites. TheResults
smallest observed internal fragments immediately gen-
erated with a rapid formation rate (as typical for PA28-PA28 Induces Double Cleavages
induced DCP formation) are heptamers (e.g., FPDITHIThe sequences of the peptide substrates used are
from the JAK1(D) peptide). Generally, we observe ashown in Figures 1A, 1D, and 1G with the MHC ligand
length of 7–12 amino acids for the dominant DCPs. Inparts underlined. For the JAK1 protein, two peptides
one case, formationof an internal hexamerpeptide (8–13were tested. The first one, designated JAK1, is a 21-
from JAK1: SYFPEI) was observed in the presence ofmer according to the original sequence. The second
PA28. However, formation of this product does not fol-one, designated JAK1(D), is two amino acids shorter at
low typical DCP kinetics as observed under PA28. Itsthe N-terminus and contains a conservative exchange
increase is preceded by the strong initial increase of(E to D) in position 5 of the MHC ligand. The reason
SYFPEITHI and correlates with decrease of SYFPEITHIto use the latter peptide was the following: the E-to-D
at later time points (data not shown). Conclusively,exchange was introduced originally for a different pur-
SYFPEI is most likely not generated directly from thepose, namely to allow the mass spectrometric distinc-
substrate by a double-cleavage, but instead fromtion of nonamer products generated in digests involving
SYFPEITHI by a single consecutive cleavage.two competing JAK1-derived peptides with different
The observed PA28-mediated production of DCPs isflanking residues. Since the variant peptide had better
rapid and not preceded by an increase in the generationsolubility than its 19-mer counterpart without the ex-
of SCPs. Therefore, one attractive hypothesis is that inchange, it was initially used for the PA28 experiments.
the presence of PA28, DCPs are made directly, possiblySubsequently, a soluble peptide with the correct se-
by coordinated double-cuts. On the other hand, DCPsquence was obtained by including two additional resi-
in the absence of PA28 might be generated by twodues at the N-terminus (JAK1 21-mer).
consecutive, independent single-cuts with SCPs asThe HPLC profiles of products generated after 5 hr in
cleavage intermediates. This mechanism might be re-proteasome digests with and without PA28 strongly dif-
flected by the fact that DCP generation in the absencefer from each other, no matter which of the three sub-
of PA28 is slow and preceded by a strong initial rise ofstrates is considered (Figure 1). Peptides resulting from
the corresponding SCPs.a single cleavage of the substrate (single-cleavage prod-
ucts [SCPs]) were identified as the main products in
the absence of PA28 (Figures 1B, 1E, and 1H). In its Enhanced Generation of MHC Ligands
How does PA28 influence the generation of MHC classpresence, far fewer of those SCPs were found; instead
internal fragments generated by two flanking cleavages I ligands? For the JAK1 peptide, the mainproduct gener-
ated by the proteasome in the presence of PA28 is(double-cleavage products [DCPs]) occurred as the pre-
dominant products (Figures 1C, 1F, and 1I). It should SYFPEITHI. This peptide is identical to the MHC ligand
(Figures 1C and 2B). Similarly, SYFPDITHI is the mainbe noted that ion currents in general do not allow a
Dual Cleavages Induced by PA28
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Figure 1. Influence of PA28 on the Generation of Single-Cleavage Products and Double-Cleavage Products by the 20S Proteasome
Amino acid sequences of the 21-mer peptide JAK1 (positions 348–368) (A), the homologous 19-mer peptide JAK1(D) (positions 350–368) (D),
and the 25-mer peptide from MCMV pp89 protein (positions 162–186) (G). The JAK1 peptide contains an H-2Kd ligand; and the pp89 peptide,
an H-2Ld restricted CTL epitope (underlined). Products generated after 5 hr from the peptide substrates by the 20S proteasome in the absence
(B, E, and H) and in the presence of PA28 (C, F, and I) were separated by RP-HPLC and detected by ESI-MS. The identity of dominant products
is indicated. Asterisks denote peaks not derived from the substrate.
product generated from the variant JAK1(D) peptide in TAP-mediated transport and could give rise to the final
MHC ligand by N-terminal trimming in the ER. In fact, athe presence of PA28 (Figures 1F and 2G). This finding
is possibly reflected by the in vivo situation, where SYF- weak translocation efficiency has been observed for the
pp89 CTL epitope under consideration (G. Geginat etPEITHI is an exceptionally abundant MHC ligand (10,000
copies per cell) (Falk et al., 1991). For the pp89 peptide, al., unpublished data).
the case is clear, too, but more complicated: although
the main cleavage product of the pp89 substrate under Effect of Substrate Concentration
Figure 4A illustrates some general considerations aboutPA28 is peptide 8–15 (which is short of the N-terminal
residue as compared to the CTL epitope; Figures 1I and the expected effects of increasing substrate concentra-
tions on product formation rates in the early time course2L), the generation of the CTL epitope (peptide 7–15) is
also dramatically enhanced by PA28 (Figures 2M and of the kinetics. If DCPs are the result of consecutive
single-cleavages, the substrate binds to the catalytic3A). Moreover, at early time points (<8 hr) formation of
the CTL epitope is almost entirely PA28-dependent. Like site of the proteasome and is first converted into an
SCP (i.e., primary product). After dissociation from themost other peptides generated in our digests, the iden-
tity of peptide 7–15 was unequivocally confirmed by binding site the SCP may rebind and is then further
cleaved to yield the DCP (i.e., secondary product). Forfragmentation in ms/ms experiments.
In addition, the second most abundant fragment gen- primary products, increasing substrate concentration
([S]) will lead to increasing initial slopes until saturationerated in the presence of PA28, peptide 5–15 (Figure
1I), might play a role as a precursor of the CTL epitope. is reached. On the other hand, increasing [S] will also
increasingly compete with SCP for binding to activeIts formation rate is strongly enhanced in the presence
of PA28 (Figures 2M and 3B). Since peptides carrying sites, leading to an inhibition of SCP conversion to
DCPs. Therefore, increasing [S] will suppress initiala proline at position 2 are not well accepted by TAP in
translocation assays (Neefjes et al., 1995; Neisig et al., slopes of DCP formation, because of competition with
SCPs for catalytic sites. Only if the DCP is generated1995), fragment 5–15 might be a better substrate for
Cell
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Figure 2. Summary of the Influence of PA28 on Generation of SCPs and DCPs
Amino acid sequence of the three substrate peptides with major (long arrows) and minor (shorter arrows) cleavage sites indicated (A, F, and
K). Time course of the generation of the dominant double-cleavage products (DCPs) SYFPEITHI (8–16 from JAK1), SYFPDITHI (6–14 from
JAK1(D)) and PHFMPTNL (8–15 from pp89) in the absence (open circles) or presence (closed squares) of PA28 (B, G, and L). Summary of the
amount of several DCPs generated from the three substrates by the 20S proteasome in the absence (open columns) or presence (solid
columns) of PA28 (C, H, and M). These graphs show the relative amounts of products produced after 5 hr. The amount of DCPs generated
with PA28 was arbitrarily set to 1. Time course of the generation of main single-cleavage products (SCPs) SYFPEITHIVIKES (8–21 from JAK1),
SYFPDITHIVIKES (6–19 from JAK1(D)), and RLMYDMYPHFMPTNL (1–15 from pp89) in the absence (open circles) or presence (closed squares)
of PA28 (D, I, and N). Summary of the amount of several SCPs generated from the three substrates by the 20S proteasome in the absence
(open columns) or presence (solid columns) of PA28 (E, J, and O). These graphs show the relative amounts of products produced after 5 hr.
The amount of double-cleavage products generated with PA28 was arbitrarily set to 1. Ion currents are always shown on linear scales.
by a coordinated double-cleavage should its formation strongly argue for a consecutive single-cleavage mech-
anism being responsible for the very weak PA28-inde-kinetics behave like that of a primary product.
To compare these predictions with experimental data, pendent formation of DCP.
In the presence of PA28 and for [S] < 180 mM (Figurewe determined the formation of the main DCP of the
pp89 peptide (8–15), corresponding SCPs (1–15, 8–25),
and terminal fragments (1–7, 16–25) over time with in-
creasing substrate concentrations. We introduce the
term “terminal fragment” (in addition to SCP and DCP)
to designate cleavage products that can be generated
together with either SCPs or DCPs; e.g., terminal frag-
ment 1–7 can be generated by single cleavage activity
(together with SCP 8–25) or by double-cleavage activity
(together with DCP 8–15 and terminal fragment 16–25).
The formation kinetics of terminal fragments therefore
depend on the particular cleavage mechanism involved.
Without PA28 (Figure 4B), SCPs and terminal fragments
at all substrate concentrations display formation kinet-
ics as predicted for primary products. Saturation in the
very early time course is already reached at about [S] 5
30 mM, because no further increase in initial slope is
Figure 3. PA28 Enhances the Generation of the pp89 CTL Epitope
evident at higher [S]. Nevertheless, only very little 8–15 and a Potential Precursor thereof
is formed. When looking at the 8–15 formation curves
Time course of the generation of the dominant T cell epitope (peptide
on an enlarged scale (Figure 4E), initial slopes appear 7–15) from the pp89 substrate (A) and of a potential precursor (pep-
actually suppressed by increasing [S], as predicted for tide 5–15) thereof (B) in the absence (open circles) or presence
(closed squares) of PA28.secondary cleavage products. Therefore, these results
Dual Cleavages Induced by PA28
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Figure 4. Effects of Increasing Substrate
Concentration on the Generation of SCPs and
DCPs by the 20S Proteasome in the Presence
or Absence of PA28
(A) Prediction for the formation kinetics of
SCPs and DCPs from consecutive single cuts
at early time points. Numbers 1 to 5 indicate
proteasome digests with increasing sub-
strate concentration. [P1] indicates the con-
centration of primary product after the first
cleavage event; [P2], the concentration of
secondary product after the second cleavage
event. The generation of primary product (P1)
increases with higher substrate concentra-
tion ([S]) over time until the substrate is in
excess and all active sites of the proteasome
are saturated. At this concentration, the in-
crease of P1 is predicted to be linear (as indi-
cated for concentration 5). The lower [S], the
earlier it is too low to compete for the second
cleavage event and the earlier P1 is converted
into P2 (concentrations 1–4). At concentration
5, P1 will decrease much later in the kinetic
when the substrate is not in excess anymore
(not shown). The formation of secondary
product (P2) should be slower with increasing
substrate concentration because more sub-
strate competes with P1 for the active sites
of the proteasome. After all of the substrate
is converted into P2, its concentration might
stay constant (dashed line) ormight decrease
(solid line) because of subdominant further
cleavages (shown for concentration 1 and 2).
If a DCP is generated by two coordinated
cleavages the kinetics of product formation
should appear like the kinetics of a SCP [P1].
(B) Measured formation of DCP 8–15, SCPs
8–25 and 1–15, and terminal fragments 16–25
and 1–7 with increasing substrate concentra-
tion (10, 30, 90, 180, and 300 mM) in the ab-
sence of PA28 over a time period of 8 hr.
(C) Formation of the same products in the
presence of PA28 and for substrate concen-
trations between 10 and 180 mM.
(D) Formation of the same products in the presence of PA28 at a substrate concentration of 300 mM.
(E) Graph showing the production of DCP 8–15 in the absence of PA28 at enlarged scale. All graphs show one out of two individual experiments
with identical results. All graphs belonging to the same product in (B), (C) and (D) are drawn with the same relative linear scale and can be
compared directly.
4C) the situation is profoundly changed, in that genera- strongly increased formation, suggesting a single-cleav-
age mechanism now being active. This apparently hap-tion of 8–15 is fast and efficient and its initial formation
rate increases with increasing [S], as is predicted for a pens at the expense of the double-cleavage process
that is either reduced, as observed for DCP 8–15, orprimary product. In contrast, formation of SCPs 1–15
and 8–25 is now very weak and only slightly enhanced remains constant, as observed for DCP 7–15 (see be-
low). Interestingly, SCPs 1–15 and 8–25 display a higherwhen increasing [S], while terminal fragments 1–7 and
16–25 show increases in formation rate corresponding formation rate compared with thesituation without PA28
(Figure 4B), indicating that the catalytic capacity of theto that of peptide 8–15. The finding that products 1–7,
8–15, and 16–25 share the same kinetic characteristics proteasome is enhanced by PA28.
Since DCP formation under PA28 is characterized byin this experiment argues for 8–15 being formed as a
primary product together with its terminal fragments 1–7 a rapid increase, it is very likely that substrate inhibition
data as obtained for themain product 8–15 are represen-and 16–25. This is also supported by the fact that the
increase of theDCP 8–15 is not paralleled by a significant tative for all other DCPs that show the same kinetic
signature. To demonstrate that the same PA28-medi-increase of 1–15 or 8–25 that could lead to 8–15 forma-
tion after a second cleavage event. The disappearance ated mechanism is responsible for the formation of less
dominant DCPs, substrate inhibition data were obtainedof terminal fragments 16–25 and 1–7 after more than 4
hr is explained by further cleavages at thesites indicated for the CTL epitope, peptide 7–15 (Figures 5A–5C). A
comparison with corresponding data as shown for pep-in Figure 2K.
At the highest substrate concentration used in this tide 8–15 (Figures 4B–4D; leftmost graphs) allows the
conclusion that the CTL epitope is actually generatedexperiment (300 mM; Figure 4D), saturation for DCP for-
mation in the presence of PA28 has been reached. Sur- by the same dual-cleavage activity: in the absence of
PA28, both DCPs are produced only weakly and thereprisingly, SCPs and terminal fragments now display a
Cell
258
Figure 6. Model for the Cleavage Mechanism of the 20S Protea-
some in the Absence or Presence of PA28
This model makes neither any assumptions on the number of the
catalytic sites or their geometry nor implications on the stoichiome-
try of interactions with PA28 or the 19S cap structure. Furthermore,
we do not want to suggest that coordinated dual cleavages are only
possible between b subunits of different b rings.
(A) In the absence of PA28 the b subunits of the 20S proteasome
perform single cleavages of the substrate.
(B) Upon binding, PA28 induces a conformational change that allows
Figure 5. Influence of Increasing Substrate Concentration on the two neighboring b subunits to participate in coordinated double-
Formation of the pp89-Derived CTL Epitope, DCP 7–15 cleavages on the same substrate molecule. The two cooperating b
(A) Measured formation of DCP 7–15 with increasing substrate con- subunits might be located within different b rings (as shown in the
centration (10, 30, 90, 180, and 300 mM) in the absence of PA28 diagram) or within the same b ring.
over a time period of 8 hr. (C) At very high concentrations, free substrate molecules compete
(B) Formation of DCP 7–15 in the presence of PA28 and for substrate for the binding of one substrate molecule to two active sites and
concentrations between 10 and 180 mM. the proteasome again performs single cleavages as in the absence
(C) Formation of DCP 7–15 in the presence of PA28and ata substrate of PA28 but with a higher activity.
concentration of 300 mM. All graphs are drawn with the same relative
linear scale and can be compared directly.
6). The cartoon shows a section of the 20S proteasome
cut along the longitudinal axis with one of the subunits
of each ring, and one of the subunits of the PA28 com-is no increase induced by higher substrate concentra-
tions. In its presence, formation of both DCPs is strongly plex. An assumption made in this model is that all sub-
strate molecules and possible cleavage intermediatesenhanced by increasing [S]. In addition, for both DCPs
an increase of substrate concentration exceeding 180 have access toall catalytic sites. This situation is implied
by practically identical cleavage site preferences in themM does not lead to a further increase in the formation
rate. presence and absence of PA28. According to our model,
in the absence of PA28 (Figure 6A) a substrate is cleaved
once, diffuses off the active site, and rebinds for theSubstrate Decay Rates
In addition to influencing the cleavagemechanism, PA28 second cleavage to occur. A DCP is therefore generated
by two consecutive single-cleavages with a diffusiblebehaves as an overall activator of substrate degrada-
tion, as described previously for fluorogenic peptides cleavage intermediate. This explains the observed kinet-
ics for SCPs and the suppression of the generation of(Ma et al., 1992). Substrate decay with time is exponen-
tial as expected for a (pseudo-) first-order reaction. In DCPs at increasing substrate concentrations (Figures
4B and 4E). In the presence of PA28 (Figure 6B), thethe presence of PA28, the decay of the pp89 substrate
peptide is slightly increased. At a substrate concentra- catalytic activity is enhanced, possibly induced by con-
formational changes after PA28 binding, and the protea-tion of 300 mM, this effect is more pronounced (data not
shown) and compares well with the strongly increased some is now able to perform coordinated dual-cleav-
ages of the substrate. Dual cleavage might occur viaformation of SCPs at this substrate concentration. How-
ever, a PA28-mediated increase in overall substrate two coordinated single-cleavage events, or the second
cut might be performed on a substrate intermediate thatturnover rate appears to be substrate dependent, since
it was not observed for the JAK1-derived peptides at is still bound to one b subunit as an acyl-intermediate
(Lo¨we et al., 1995) and is therefore not diffusible. Bothlow substrate concentrations (compare Figure 1).
double-cleavage mechanisms would explain why in the
presence of PA28 DCPs appear with similar kinetics asModel for PA28 Function
Our results lead us to propose the following model for SCPs in the absence of PA28 because they are pro-
duced as primary cleavage products. The maximumthe influence of PA28 on proteasome function (Figure
Dual Cleavages Induced by PA28
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slope of PA28-dependent DCP formation appears to this model does not completely explain our findings,
since the rebinding of an intermediate that is freely dif-be higher when compared with PA28-independent SCP
fusible inside the 20S particle should also be competedformation. This finding might reflect that PA28-induced
for by increasing the substrate concentration. We thinkconformational changes lead to an increase in substrate
that our data are best explained by assuming that theaffinity, higher intrinsic activity of the catalytic sites, or
intermediate remains bound to the inner proteasomeboth. The observation that in thepresence of PA28 DCPs
surface until the second cleavage occurs. This might begenerated with a high initial formation rate have at least
facilitated by cooperative binding of substrate mole-seven amino acid residues might be related to the 28 A˚
cules to two b subunits or by formation of a covalentlydistance between two catalytic sites, as determined for
attached acyl-intermediate, as suggested (Lo¨we et al.,the proteasome of T. acidophilum (Lo¨we et al., 1995)
1995).and proposed to be a molecular ruler (Wenzel et al.,
Interestingly, it has been observed that a particular1994). In the presence of PA28 and at substrate concen-
internal nonamer fragment from oxidized insulin b chaintrations that are saturating for DCP formation (around
(5–13) is generated by the 20S proteasome without a300 mM; see Figure 4D), the 20S proteasome displays
lag period during which the concentrations of potentiala change in cleavage mechanism. It now also generates
intermediates (1–13, 5–30) rise to a maximal value, indi-high levels of SCPs.Such a behavior can be explainedby
cating coordinated cleavages (Dick et al., 1991). Never-competition. Excessively high substrate concentrations
theless, the majority of products obtained in this studywould favor the binding of substrate molecules to b
were generated by single cleavages. This finding mightsubunits on a one-to-one basis over binding of one sub-
indicate that for certain substrates the 20S proteasomestrate molecule to two b subunits (Figure 6C). As the
is capable of performing double-cleavages in the ab-proteasome is more active when bound to PA28, the
sence of PA28.generation of SCPs in these conditions is enhanced
Complex kinetic behavior of the 20S proteasome inwhen compared to the proteasome without PA28. These
the absence of PA28 has been observed with low molec-considerations can also explain why the overall sub-
ular weight substrates and inhibitors (Stein et al., 1996,strate turnover increases even at conditions which are
and references therein). These findings likely reflect co-saturating for DCP formation: the available catalytic
operative interactions between multiple binding sites:sites perform individual single-cuts instead of two cata-
occupation of one site apparently modulates the activity
lytic sites performing double-cuts. Because detailed
at other sites. The 20S proteasome might correspond-
knowledge of the topology and number of catalytic sites
ingly exist in several conformational states that may
of eukaryotic proteasomes is not yet available, other
interconvert spontaneously or be induced by ligand
models with diffusible cleavage intermediates not inhib- binding (Stein et al., 1996). It is tempting to speculate
itable by excess of substrate cannot formally be ex-
that PA28 promotes a concerted cleavage mechanism
cluded. for (poly)peptides by stabilizing certain conformational
states of the 20S proteasome.
Although we have observed a strong preference forDiscussion
double-cleavages in the presence of PA28, it should
be noted that single-cleavage activity is obviously not
We have shown that PA28 changes the cleavage behav-
excluded under PA28, especially when looking at pep-
ior of the 20S proteasome in a characteristic manner:
tides too small for (further) double-cleavages (e.g., SYF-
Without PA28, the proteasome cuts substrates by con- PEITHI from the JAK1 peptide), at later time points or
secutive and independent single cleavages; internal at very high substrate concentrations (Figure 4D). We
fragments requiring two cleavages are among the prod- also observed that small differences in sequence and
ucts but occur later in the course of time and only after length, as between JAK1 and JAK1(D), apparently influ-
a marked increase of single-cut precursors. Upon asso- ence the exact product pattern. Understandably, bind-
ciation with PA28, proteasomaldouble-cleavage activity ing and appropriate orientation of a substrate peptide
leading to internal fragments of 7 amino acids or longer around and between two active sites depends on se-
is strongly enhanced even at very early time points. The quence properties of the peptide, especially of those
kinetics of this reaction imply that the second cleavage residues oriented toward the inner b subunit surface.
does not occur on a diffusible intermediate but rather Whether or not the observed double cleavages hap-
on an intermediate that remains associated with the pen simultaneously, an optimized production of internal
proteasome. Alternatively, one would have to postulate fragments induced by PA28 is of paramount relevance
a diffusible intermediate that cannot be competed by for antigen processing. If proteasome cleavages were
excess substrate. always uncoordinated, the probability for a nearby sec-
It is also possible that the attachment of PA28 influ- ond cleavage close to the site of the initial cleavage
ences both the entry of substrate molecules into the under in vivo conditions would probably be very small
lumen of the 20S particle as well as the exit of products. due to competition by other peptides and the possibility
Thus, one might explain the observed PA28-mediated of premature release of intermediates from the protea-
effect by assuming that PA28 simply retains cleavage some. It is evident that the efficient and rapid one-step
intermediates and by doing so increases the probability production of peptides fitting with the length require-
for substrates to be cleaved twice before their release ments for optimal TAP transport and of the same or
into the surrounding medium. Because those luminal slightly larger size as optimal for MHC class I ligands is
intermediates are short-lived and trapped inside the pro- a considerable advantage for antigen processing and
the immune response.teasome, they are not detected inour analysis. However,
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The most abundant natural ligand of H-2Kd molecules this might explain why the ratio of product formation
(48 hr without PA28 versus 24 hr with PA28) is changedof P815 cells (likely to express PA28 constitutively) is
SYFPEITHI, derived from the normal self protein JAK1 or even reversed as compared with our present data at
24 hr. Although in the earlier study HPLC profiles for(Harpur et al., 1993). Under PA28, this peptide, respec-
tively its homolog SYFPDITHI, is directly cut out from early time points (1.5 hr, 5 hr) were shown, peptide prod-
ucts had not been identified. Moreover, thepeak profilesthesubstrate, and it is the most abundant product. Thus,
it is likely for this case that the MHC ligand is directly are not directly comparable with those of the present
study since a different RP-HPLC method was used. Inand efficiently produced by proteasome plus PA28. In
no other instance has a comparable production of a addition, it seems possible that methodological differ-
ences contribute to discrepancies in the product forma-class I ligand as the main product by the proteasome
been observed. This efficient one-step processing can tion rates observed. Digests in the previous study were
performed in an incubation buffer of different composi-explain the exceptionally high copy number of this par-
ticular MHC ligand incells (Falk et al., 1991). The second- tion and a different source of PA28 protein was used
(rabbit erythrocytes versus human placenta). However,most abundant product produced by proteasome plus
PA28 from the JAK1(D) substrate is a 7-mer, lacking the our present results have been reproduciblewith different
preparations of proteasome and PA28.first two residues of SYFPDITHI. The homolog 7-mer
FPEITHI is also effectively produced from the JAK1 sub- Clear specificity for individual cleavage sites by the
20S proteasome is not evident, and no influence of PA28strate. Most significantly, both FPEITHI and SYFPEITHI
were isolated from whole cell extracts of P815 with on individual sites is observed. However, in the two
cases studied here, the dominant dual-cleavage prod-monoclonal antibodies against SYFPEITHI, whereas any
longer peptides were not detected (T. P. D., unpublished ucts are cut after hydrophobic residues, suggesting
some degree of selectivity. Since the peptides deriveddata). Thus, the peptides found in cells do well reflect
the products of the 20S proteasome with PA28, indicat- from JAK1 and JAK1(D) share the dominant, but differ
in minor cleavage products, amino acid substitutions ining that our observations are of in vivo relevance.
From the one-step processing of SYFPEITHI it does the vicinity of cleavage sites as well as substrate length
seem to influence specificity of the proteasome. In anynot necessarily follow that all MHC ligands are produced
this way. In contrast, its exceptional abundance (10,000 instance, the coordinated selection of dual cleavage
sites is not only determined by a simple length ruler.Kd ligands per cell) suggests that other ligands might
be produced in a less efficient manner. One example We hypothesize that the interaction of the peptide with
the internal proteasome surface between or adjacentfor such a situation is the MCMV pp89 peptide. The main
double-cleavage activity of the proteasome complexed to active sites mediates a degree of specificity. The
knowledge of such specificity should be of value for thewith PA28 destroys this sequence; nevertheless, signifi-
cant amounts of YPHFMPTNL are produced only in the prediction of naturally processed T cell epitopes within
protein sequences, if combined with the application ofpresence of PA28, and even more of a putative precursor
DMYPHFMPTNL that requires N-terminal trimming be- MHC motifs.
The 20S proteasome, with or without PA28, is not ablefore becoming the final MHC ligand is produced.
The in vivo relevance of our pp89 cleavage data has to digest intact proteins. Thus, one could speculate that
the proteasome might be attached to PA28 at one endbeen shown recently: fibroblasts expressing pp89 and
overexpressing PA28a were lysed more efficiently by and the 19S cap at the other; such a complex might be
able to degrade ubiquitylated proteins by dual cleavage.MCMV-specific CTL than their regulator-normal coun-
terparts. Moreover, specific CTL lysis of influenza- However, recent data suggest that inside a cell the pool
of 20S particles is only partially associated with limitinginfected target cells was also much higher when PA28
was overexpressed. Even for alloreactive CTL, lysis was amounts of 19S cap or PA28 (Yang et al., 1995). There-
fore it would appear more likely that besides free 20Shigher with the latter cells (Groettrup et al., 1996). Thus,
the in vitro results with 20S proteasomes under PA28 proteasomes at least two different subpopulations of
20S proteasome complexes exist, singly capped withare well reflected by in vivo data, indicating that the
function or at least one of the functions of PA28 is the either 19S cap or PA28. The 19S-capped proteasomes
could perform the initial cleavages on intact proteins,optimization of antigen processing.
Our present findings are not in agreement with earlier generating relatively large intermediary fragments,
which then become a substrate for the PA28-cappedfindings showing the reduced formation of several DCPs
derived from the same pp89 25-mer substrate (5–15, proteasome, leading to small peptide fragments, as
described in this study. Alternatively, if the 19S cap7–15, 8–15) in the presence of PA28 (Groettrup et al.,
1995). While these results are difficult to reconcile at complex is not actually involved, another supplier of
unfolded or preprocessed substrate for the PA28-pro-first appearance, there are several differences between
the two studies that might account for the apparent teasome complex must exist in the cell.
Studies with the Thermoplasma proteasome have leddiscrepancy. Both studies demonstrate that PA28
changes the quantity of peptides produced. However, to the “molecular ruler” hypothesis (Wenzel et al., 1994),
which postulates that the minimal distance between twoin the previous study peptide products were identified
and quantitated only after complete turnover of the sub- neighboring active sites dictates the product length to
be about 7 amino acid residues. Although not actuallystrate and digests with and without PA28 were com-
pared after different incubation times (24 and 48 hr, demonstrated, the postulated molecular ruler could re-
flect coordinated dual cleavages taking place in therespectively). Since formation of DCPs in the absence
of PA28 continues at a low level between 24 and 48 hr, archaebacterial proteasome by default. It is therefore
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7.8]; 2 mM MgAc2; 1 mM DTT). PA28 was added in 5-fold molartempting to speculate that PA28 association, by induc-
excess over the proteasome. Aliquots of 50 ml were removed ating coordinated dual cleavages performed between
each time step, separated by RP-HPLC (SMART-System, equippedneighboring active sites, confers a kind of molecular
with a mRPC C2/C18 SC 2.1/10 column; Pharmacia, Freiburg, Ger-
ruler to the eukaryotic proteasome. many). Eluent A: 0.05% TFA; eluent B: 70% acetonitrile containing
We have established a fundamental function of PA28: 0.05% TFA. Gradient: 23%–63% B in 20 min; flow rate: 50 ml/min,
gradient started 5 min after sample injection.it changes the cleavage mechanism of 20S protea-
somes, resulting in the efficient production of double
Peptide Analysis by Mass Spectrometrycleavage products. These peptides are typically 7–12
Analysis was performed on-line by a tandem quadrupole mass spec-amino acids long and, in the two cases studied here,
trometer (TSQ 7000; Finnigan MAT, Bremen, Germany) equippedareeither identical toclass I ligands, or areslightly longer
with an electrospray ion source. Each scan was acquired over the
and therefore putative precursors of ligands. That these range m/z 250–1000 in 2 s. The peptides were identified by their
in vitro findings are relevant in vivo is illustrated by the molecular mass calculated from the m/z peaks of single or multiple
existence of the cleavage products in total peptide ex- charged ions. Additionally, the identity of main cleavage products
was confirmed by fragmentation with argon atoms in ms/ms experi-tracts of cells, and by the more efficient recognition of
ments. Because of inefficient adsorption to the RP-column, peptidePA28-overexpressing virus-infected cells by CTL
products smaller than five residues are not always detectable.(Groettrup et al., 1996). In addition, our results lead to
at least one critical new question: since the cleavage
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